Teleflex’s Titan SGS Stapler shows efficacy in gastroesophageal reflux disease

Teleflex (TFX) announced the publication of a new retrospective analysis of clinical data associating the use of the Titan SGS Stapler with reduced rates of post-operative gastroesophageal reflux disease, or GERD, following robotic-assisted laparoscopic sleeve gastrectomy, or LSG, compared with traditional multi-fire surgical staplers. The retrospective study comprised 257 patients who underwent robot-assisted sleeve gastrectomy using the Titan SGS Stapler or multiple fires of a traditional linear stapler between 2016 and 2023. Sleeve gastrectomy is the most common weight-loss surgery in the U.S. A 2024 review of 109 studies found “a persistent concern for worsening and de novo GERD” after sleeve gastrectomy. The Titan SGS Stapler is designed to improve the potential to resolve GERD and nausea. The publication reports that at one-year post-procedure, significantly fewer patients in the Titan SGS Stapler cohort reported having GERD vs. the multi-fire cohort and significantly fewer patients in the Titan SGS Stapler cohort developed de novo GERD vs. the multi-fire cohort. In previous retrospective studies, the Titan SGS Stapler has been associated with significantly reduced operative times, less post-op nausea and vomiting and the potential for increased operational efficiencies and significant reductions in LOS and readmissions